Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-30

Clinical Trial Update: Pre- and Postoperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

This study assesses pre- and postoperative chemotherapy including bevacizumab for potentially curable metastatic colorectal cancer in Phase 1 and Phase 2, and t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bevacizumab (bevacizumab)

Snippet

Sponsor: Austrian Society Of Surgical Oncology | Conditions: Metastatic Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED